Wednesday, 24.06.2026, Calendar Week 26, 175th day of the year, 190 days remaining until EoY.

Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.

The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

US14159C2026

Reset filter

Do you already know our new terminal view? Click here.

FIGI: BBG013P0VV65

CDIO

Cardio Diagnostics Holdings, Inc.

GICS: - · SECTOR: EQTY · SUB-SECTOR: Biotechnology

NAME

Cardio Diagnostics Holdings, Inc.

ISIN

US14159C2026

TICKER

CDIO

MIC

XNAS

REUTERS

CDIO.OQ

BLOOMBERG

CDIO US

Wed, 24.06.2026 Cardio Diagnostics

Newsfeed

Atlas Healthcare Physicians to Cover Cardio Diagnostics’ Precision Cardiovascular Medicine Tests Across Its Network | Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc. to Showcase Precision Cardiovascular Solutions at Four National Benefits Conferences in June | Cardio Diagnostics Holdings, Inc.

CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, February 19, 2026 | Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc. to Host Investor Call on Wednesday, February 18, 2026 | Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics, Aimil Ltd. and Dr. Lal PathLabs Limited Partner to Launch the PrecisionCHD™ Test in India | Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc. and Southdale YMCA Announce New Heart Health Partnership to Serve the Edina, Minnesota Community | Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Receives Final Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS) | Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc. to Present Data Demonstrating PrecisionCHD’s Ability to Detect INOCA and MINOCA at the American Heart Association Scientific Sessions | Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc. and YMCA of East Tennessee Partner to Bring Heart Health Education and Advanced Testing to East Tennessee Community | Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc. Expands Provider Network, Adding 15 New Provider Organizations From Across the United States | Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Receives Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS) | Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Enters Into an Agreement with AGEPHA Pharma to Advance Precision Assessment and Management of Inflammation Associated with Coronary Heart Disease | Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Secures Japanese Patent for AI-Driven Cardiovascular Disease Detection Technology | Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price | Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Broadens Access to Precision Cardiovascular Care with New Practice Partnerships Across U.S. Mainland and Puerto Rico | Cardio Diagnostics Holdings, Inc.